CoChat

A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report

Open access
Read, John, Renton, Julia, Harrop, Christopher, Geekie, Jim, Dowrick, Christopher · 2020 · Therapeutic Advances in Psychopharmacology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index; 7 of the 26 sources its claims cite were checked for support.

Abstract

Background: In 2019, a literature review indicated that more than half of people who try to come off antidepressants experience withdrawal effects. Both the National Institute of Health and Care Excellence and the Royal College of Psychiatrists updated their positions in line with that review, and Public Health England published a 152-page report called Dependence and withdrawal associated with some prescribed medicines: an evidence review. The report made several recommendations relevant to general practice. Method: In order to facilitate implementation of these recommendations, an online survey was designed to explore United Kingdom general practitioner (GP) experiences, opinions, knowledge and needs in relation to depression, ADs and withdrawal. A total of 66 GPs had completed the survey when COVID-19 occurred. Results: In keeping with previous findings, this small sample of GPs had a predominantly psycho-social perspective on the causes of, and treatments for, depression. They broadly considered ADs effective for moderate/severe depression and ineffective for minimal/mild depression, for which they preferred psychological therapies and social prescribing. There was a marked lack of consistency in GPs’ knowledge about the incidence and duration of withdrawal effects. Only a minority (29%) felt their knowledge about withdrawal was ‘adequate’ and fewer (17%) believed this about their ‘Ability to distinguish between withdrawal effects and return of the original problem (e.g. depression)’. Two-thirds (68%) would like more training on these matters. Conclusion: It is hoped that even this small sample will be helpful when designing, and seeking funding for, GP training programmes, and when implementing the PHE recommendations for support services, based in the primary care system, for the millions of people contemplating or initiating withdrawal from ADs every year in the UK.

Overview

CoChat Summary

TL;DR

A survey of 66 UK general practitioners found predominantly psychosocial beliefs about depression, mixed knowledge about antidepressant withdrawal, and strong demand for more training. It was intended to help implement the 2019 Public Health England recommendations, but recruitment stopped because of COVID-19 and the sample was very small.

Key findings

  • Most GPs (53/66; 80%) thought social causes contributed more than bio-genetic causes to depression; the most endorsed causes were child abuse/neglect and violence/rape in adulthood, while genetic predisposition and chemical imbalance were least endorsed.
  • GPs viewed antidepressants as much more effective for moderate/severe depression (25% “very effective,” 68% “somewhat effective”) than minimal/mild depression (5% “very effective,” 28% “somewhat effective,” 31% “not at all effective”); for minimal/mild depression, antidepressants were the 7th most endorsed treatment option.
  • Withdrawal knowledge was inconsistent: 27%, 24%, and 24% estimated that no more than 10% of patients experience withdrawal after 3 months, 1 year, and 3 years respectively, and 40% thought withdrawal was experienced by no more than 30% even after 3 years. Only 29% rated their knowledge about withdrawal as “adequate,” 14% rated their ability to distinguish withdrawal from relapse as “adequate,” and 68% wanted more training.
  • Most GPs (83%) thought the current antidepressant prescribing rate was too high; 77% said they “always” or “most of the time” inform patients about possible withdrawal effects; all 56 who answered the services question ticked NHS provision, with 48% also endorsing NGOs/voluntary sector.

Methods

  • An online questionnaire was designed from the research literature, trialled on three GPs, and advertised via a BMJ article and social media, including the “Resilient GP” Facebook group.
  • Between 7 February and 10 March 2020, 66 UK GPs completed the survey; recruitment ceased when COVID-19 occurred.
  • Quantitative multiple-choice data were reported as descriptive statistics without demographic analysis due to small numbers; open-ended responses were reported as numbers of similar or identical responses.

Limitations

  • The paper states the very small sample size, representing only about 0.15% of GPs in England and effectively none from the rest of the UK, would normally prohibit journal submission; it also states the most likely bias is disproportionate inclusion of GPs with particular interest in and knowledge of antidepressants and withdrawal, so findings on psychosocial perspectives should be received with caution, and perceived inadequacy or inaccurate beliefs might be even more pronounced in a more representative sample.
  • The authors note that GPs’ reports of informing patients about withdrawal may reflect social desirability rather than actual practice.
  • Evident from the text: the sample was self-selected via BMJ and social media, the analysis is descriptive only with no inferential or demographic adjustment, and three participants left some questions unanswered.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/2045125320950124

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

5 Valid · 0 Not valid · 12 Not checked · 58 Own results and interpretations

31 more claims

Create a free account to see all 75 claims and to verify the 18 references still open.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 25

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Research works printed but not linked: 2

  1. Royal College of Psychiatrists. Position statement on antidepressants and depression, PS04/19. London: R.C.P, 2019.
  2. Ogden E New Zealand GPs: their perspectives on depression and antidepressants. Unpublished Doctoral Thesis, University of Auckland, NZ, 2016.

Cited by

See all 46

Metadata

Authors
Read, J., Renton, J., Harrop, C., Geekie, J., & Dowrick, C.
Affiliations
  • University of East London (GB)
  • West London Mental Health NHS Trust (GB)
  • West London NHS Trust, London, UK
  • NHS Lothian (GB)
  • University of Liverpool (GB)
Corresponding author
Read, John
Venue
Therapeutic Advances in Psychopharmacology
Published
2020-01
Volume
10
Pages
2045125320950124-2045125320950124
ISSN
  • 2045-1253 (ISSN-L)
  • 2045-1261
OpenAlex
W3080737126
Cited by
43
References
41
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 17 · 2020: 1
FWCI
4.79
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UEL Research Repository (University of East London) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
antidepressant discontinuation, antidepressants, depression, general practitioners, withdrawal effects, implementation, general practice training, mild depression, psychotherapy, social prescribing, primary care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.